Page 1 of Clinical Trials for Lantus, 344 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)
Last Updated: August 30, 2010
Condition(s): Diabetes Mellitus, Type 1
2
Completed
Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes Mellitus
Last Updated: May 10, 2012
Condition(s): Diabetes Mellitus, Type 2
3
Completed
Insulin Glargine "All to Target" Trial
Last Updated: May 4, 2011
Condition(s): Diabetes Mellitus, Type 2
4
Recruiting
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Last Updated: May 14, 2012
Condition(s): Type 1 Diabetes Mellitus
5
Completed
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin
Last Updated: April 3, 2009
Condition(s): Hyperglycemia; Diabetes
6
Completed
A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus
Last Updated: August 30, 2010
Condition(s): Diabetes Mellitus, Type 2
7
Not yet recruiting
Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analog Glargine in Type 1 Diabetic Patients
Last Updated: May 10, 2011
Condition(s): Type I Diabetes
8
Not yet recruiting
Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
Last Updated: March 25, 2009
Condition(s): Type 1 Diabetes; Hypoglycemia
9
Recruiting
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Last Updated: September 13, 2011
Condition(s): Type 2 Diabetes; Renal Insufficiency
10
Completed
Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus
Last Updated: April 30, 2012
Condition(s): Type 1 Diabetes Mellitus
11
Recruiting
Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
Last Updated: May 14, 2012
Condition(s): Type 2 Diabetes Mellitus
12
Completed
Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
Last Updated: August 3, 2010
Condition(s): Diabetes Type 1
13
Completed
Insulin Glargine at Bedtime or in AM Versus NPH
Last Updated: September 15, 2010
Condition(s): Type 2 Diabetes Mellitus
14
Recruiting
Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus
Last Updated: June 2, 2009
Condition(s): Type 2 Diabetes Mellitus
15
Not yet recruiting
A Study to Compare LY2963016 to Lantus After a Single Dose to Subjects With Type 1 Diabetes Mellitus
Last Updated: May 18, 2012
Condition(s): Diabetes Mellitus, Type 1
16
Completed
Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)
Last Updated: July 29, 2010
Condition(s): Diabetes Mellitus, Type 2
17
Completed
Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®
Last Updated: October 28, 2011
Condition(s): Type 1 Diabetes Mellitus
18
Recruiting
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
Last Updated: May 14, 2012
Condition(s): Type 2 Diabetes Mellitus
19
Completed
Perioperative Insulin Glargine Dosing Study
Last Updated: March 19, 2012
Condition(s): Diabetes; Surgery
20
Recruiting
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
Last Updated: May 14, 2012
Condition(s): Type 2 Diabetes Mellitus

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Lantus

Page 1 of Clinical Trials for Lantus, 344 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About